Pacira BioSciences Files 8-K on Financials

Ticker: PCRX · Form: 8-K · Filed: Feb 27, 2025 · CIK: 1396814

Pacira Biosciences, Inc. 8-K Filing Summary
FieldDetail
CompanyPacira Biosciences, Inc. (PCRX)
Form Type8-K
Filed DateFeb 27, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, results-of-operations, filing

Related Tickers: PCRX

TL;DR

Pacira BioSciences (PCRX) filed an 8-K detailing financial results and operations.

AI Summary

Pacira BioSciences, Inc. filed an 8-K on February 27, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located at 5401 West Kennedy Boulevard, Suite 890, Tampa, Florida.

Why It Matters

This 8-K filing provides investors with crucial updates on Pacira BioSciences' financial performance and operational status, impacting investment decisions.

Risk Assessment

Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.

Key Players & Entities

  • Pacira BioSciences, Inc. (company) — Registrant
  • February 27, 2025 (date) — Date of Report
  • 5401 West Kennedy Boulevard, Suite 890, Tampa, Florida 33609 (location) — Principal Executive Offices
  • 813-553-6680 (phone_number) — Registrant's Telephone Number
  • Pacira Pharmaceuticals, Inc. (company) — Former Company Name
  • PACIRA INC (company) — Former Company Name
  • Blue Acquisition Corp (company) — Former Company Name

FAQ

What is the primary purpose of this 8-K filing?

The primary purpose of this 8-K filing is to report on the Results of Operations and Financial Condition of Pacira BioSciences, Inc., and to include Financial Statements and Exhibits.

When was this 8-K report filed?

This 8-K report was filed as of February 27, 2025.

What is the principal executive office address for Pacira BioSciences, Inc.?

The principal executive office address is 5401 West Kennedy Boulevard, Suite 890, Tampa, Florida 33609.

What is the Commission File Number for Pacira BioSciences, Inc.?

The Commission File Number for Pacira BioSciences, Inc. is 001-35060.

What were some of Pacira BioSciences, Inc.'s former company names?

Pacira BioSciences, Inc. was formerly known as Pacira Pharmaceuticals, Inc., PACIRA INC, and Blue Acquisition Corp.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on February 27, 2025 regarding Pacira BioSciences, Inc. (PCRX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.